27430240|t|Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice
27430240|a|The number of regulatory T cells (Treg cells) and the expression of ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1; also known as CD39) and 5'-ectonucleotidase (NT5E; also known as CD73) on the Treg cell surface are increased during sepsis. In this study, to determine the factors leading to the high expression of CD39 and CD73, and the regulation of the CD39 / CD73 / adenosine pathway in Treg cells under septic conditions, we constructed a mouse model of sepsis and separated the Treg cells using a flow cytometer. The Treg cells isolated from the peritoneal lavage and splenocytes of the mice were treated with adenosine or the specific adenosine A2A receptor agonist, CGS21680, and were transfected with specific siRNA targeting E2F transcription factor 1 (E2F-1) or cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB), which are predicted transcription regulatory factors of CD39 or CD73. The regulatory relationships among these factors were then determined by western blot analysis and dual-luciferase reporter assay. In addition, changes in adenosine metabolism were measured in the treated cells. The results revealed that adenosine and CGS21680 significantly upregulated CD39 and CD73 expression (P<0.01). E2F-1 and CREB induced CD39 and CD73 expression, and were upregulated by adenosine and CGS21680. Adenosine triphosphate (ATP) hydrolysis and adenosine generation were inhibited by the knockdown of E2F-1 or CREB, and were accelerated in the presence of CGS21680. Based on these results, it can be inferred that adenosine, the adenosine A2A receptor agonist, E2F-1 and CREB are the possible factors contributing to the high expression of CD39 and CD73 on the Treg cell surface during sepsis. Adenosine and its A2A receptor agonist served as the signal transducer factors of the CD39 / CD73 / adenosine pathway, accelerating adenosine generation. Our study may benefit further research on adenosine metabolism for the treatment of sepsis.
27430240	0	9	Adenosine	T103	UMLS:C0001443
27430240	18	48	adenosine A2A receptor agonist	T103	UMLS:C2936552
27430240	50	58	CGS21680	T103	UMLS:C0055233
27430240	60	70	upregulate	T038	UMLS:C0949479
27430240	71	75	CD39	T103	UMLS:C0108783
27430240	80	84	CD73	T103	UMLS:C0000530
27430240	104	109	E2F-1	T103	UMLS:C1384539
27430240	114	118	CREB	T103	UMLS:C0056695
27430240	122	140	regulatory T cells	T017	UMLS:C0039198
27430240	162	166	mice	T204	UMLS:C0025929
27430240	181	199	regulatory T cells	T017	UMLS:C0039198
27430240	201	211	Treg cells	T017	UMLS:C0039198
27430240	235	283	ectonucleoside triphosphate diphosphohydrolase 1	T103	UMLS:C0108783
27430240	285	291	ENTPD1	T103	UMLS:C0108783
27430240	307	311	CD39	T103	UMLS:C0108783
27430240	317	336	5'-ectonucleotidase	T103	UMLS:C0000530
27430240	338	342	NT5E	T103	UMLS:C0000530
27430240	358	362	CD73	T103	UMLS:C0000530
27430240	371	380	Treg cell	T017	UMLS:C0039198
27430240	381	388	surface	T082	UMLS:C0205148
27430240	410	416	sepsis	T038	UMLS:C0243026
27430240	450	457	factors	T103	UMLS:C0005515
27430240	492	496	CD39	T103	UMLS:C0108783
27430240	501	505	CD73	T103	UMLS:C0000530
27430240	515	528	regulation of	T038	UMLS:C1327622
27430240	533	537	CD39	T103	UMLS:C0108783
27430240	540	544	CD73	T103	UMLS:C0000530
27430240	547	556	adenosine	T103	UMLS:C0001443
27430240	568	578	Treg cells	T017	UMLS:C0039198
27430240	621	632	mouse model	T038	UMLS:C2986594
27430240	636	642	sepsis	T038	UMLS:C0243026
27430240	661	671	Treg cells	T017	UMLS:C0039198
27430240	680	694	flow cytometer	T074	UMLS:C0180279
27430240	700	710	Treg cells	T017	UMLS:C0039198
27430240	729	746	peritoneal lavage	T058	UMLS:C0031148
27430240	751	762	splenocytes	T017	UMLS:C1519477
27430240	770	774	mice	T204	UMLS:C0025929
27430240	780	792	treated with	T058	UMLS:C0332293
27430240	793	802	adenosine	T103	UMLS:C0001443
27430240	819	849	adenosine A2A receptor agonist	T103	UMLS:C2936552
27430240	851	859	CGS21680	T103	UMLS:C0055233
27430240	870	881	transfected	T062	UMLS:C0040669
27430240	896	901	siRNA	T103	UMLS:C1099354
27430240	912	938	E2F transcription factor 1	T103	UMLS:C1384539
27430240	940	945	E2F-1	T103	UMLS:C1384539
27430240	950	1020	cyclic adenosine monophosphate (cAMP) response element-binding protein	T103	UMLS:C0056695
27430240	1022	1026	CREB	T103	UMLS:C0056695
27430240	1049	1081	transcription regulatory factors	T103	UMLS:C0040648
27430240	1085	1089	CD39	T103	UMLS:C0108783
27430240	1093	1097	CD73	T103	UMLS:C0000530
27430240	1103	1113	regulatory	T038	UMLS:C1327622
27430240	1140	1147	factors	T103	UMLS:C0005515
27430240	1172	1193	western blot analysis	T058	UMLS:C0949466
27430240	1198	1228	dual-luciferase reporter assay	T058	UMLS:C0022885
27430240	1254	1274	adenosine metabolism	T038	UMLS:C1158592
27430240	1304	1309	cells	T017	UMLS:C0007634
27430240	1337	1346	adenosine	T103	UMLS:C0001443
27430240	1351	1359	CGS21680	T103	UMLS:C0055233
27430240	1374	1385	upregulated	T038	UMLS:C0949479
27430240	1386	1390	CD39	T103	UMLS:C0108783
27430240	1395	1399	CD73	T103	UMLS:C0000530
27430240	1421	1426	E2F-1	T103	UMLS:C1384539
27430240	1431	1435	CREB	T103	UMLS:C0056695
27430240	1444	1448	CD39	T103	UMLS:C0108783
27430240	1453	1457	CD73	T103	UMLS:C0000530
27430240	1479	1490	upregulated	T038	UMLS:C0949479
27430240	1494	1503	adenosine	T103	UMLS:C0001443
27430240	1508	1516	CGS21680	T103	UMLS:C0055233
27430240	1518	1557	Adenosine triphosphate (ATP) hydrolysis	T038	UMLS:C1510699
27430240	1562	1571	adenosine	T103	UMLS:C0001443
27430240	1618	1623	E2F-1	T103	UMLS:C1384539
27430240	1627	1631	CREB	T103	UMLS:C0056695
27430240	1673	1681	CGS21680	T103	UMLS:C0055233
27430240	1731	1740	adenosine	T103	UMLS:C0001443
27430240	1746	1776	adenosine A2A receptor agonist	T103	UMLS:C2936552
27430240	1778	1783	E2F-1	T103	UMLS:C1384539
27430240	1788	1792	CREB	T103	UMLS:C0056695
27430240	1810	1817	factors	T103	UMLS:C0005515
27430240	1857	1861	CD39	T103	UMLS:C0108783
27430240	1866	1870	CD73	T103	UMLS:C0000530
27430240	1878	1887	Treg cell	T017	UMLS:C0039198
27430240	1888	1895	surface	T082	UMLS:C0205148
27430240	1903	1909	sepsis	T038	UMLS:C0243026
27430240	1911	1920	Adenosine	T103	UMLS:C0001443
27430240	1929	1949	A2A receptor agonist	T103	UMLS:C2936552
27430240	1964	1981	signal transducer	T038	UMLS:C1152628
27430240	1982	1989	factors	T103	UMLS:C0005515
27430240	1997	2001	CD39	T103	UMLS:C0108783
27430240	2004	2008	CD73	T103	UMLS:C0000530
27430240	2011	2020	adenosine	T103	UMLS:C0001443
27430240	2043	2052	adenosine	T103	UMLS:C0001443
27430240	2095	2103	research	T062	UMLS:C0035168
27430240	2107	2127	adenosine metabolism	T038	UMLS:C1158592
27430240	2136	2145	treatment	T058	UMLS:C0087111
27430240	2149	2155	sepsis	T038	UMLS:C0243026